Take the measurements listed in the template below, draw it out on paper, making a center line down the whole skirt pattern to help keep things perfect. After you get your measurements Add at least an inch of seam allowance to the waist, chest, and hips –> then divide these 3 measurements and the length around forearm by 2. You are only making 1 pattern of the front half of the skirt so these 4 measurements need to be divided by 2. Just for reassurance…I added a few inches around the chest, waist and hips for the first pattern, just in case. Draw out your measurements on a paper to look like the first image below! Add an inch to the bottom for hem and half inch to the sleeves. You will have this pattern to make many skirt over and over again. Tweek it if needed! If you want to do something even easier and quicker, skip to the next template!
AB - Background: Reduction in immunosuppression is considered the therapy of proven benefit for BKV infection in renal transplantation, but the use of leflunomide has also been reported. It was observed at this center that the patterns of viral load response while on leflunomide appear to fall into two distinct types. Methods: Medical records of 22 kidney and kidney-pancreas recipients at a single center who received leflunomide therapy for BKV DNAemia were reviewed. Information was collected on demographics, BKV viral loads, other antiviral therapy, immunosuppressive drug levels and doses, adverse effects, and graft and patient outcomes. Results: Eighteen of 22 cleared BKV viremia, and 12 of 22 had preserved allograft function; only two graft losses occurred in the screening era among leflunomide-treated patients. Two patterns of viral load reduction were observed, termed the "smooth" and the "zigzag" pattern, which differed in mean time to clear of BKV DNA ( vs. months, p = ). Graft preservation was correlated with lower serum creatinine (SCr) at the start of leflunomide therapy. Conclusions: Long courses and "zigzag" fluctuations in viral load can occur in patients who eventually clear BKV on leflunomide with preserved allograft function. Intermittent increases in viral load do not necessarily portend therapeutic failure. Although the utility of leflunomide is still debated in the transplant community, this information may be useful to clinicians who choose to use it in selected patients.